Orient EuroPharma Co., Ltd. (TPEX: 4120)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.10
+0.90 (1.91%)
Dec 20, 2024, 1:30 PM CST

Orient EuroPharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4,1733,3743,1403,1534,1734,823
Upgrade
Market Cap Growth
18.50%7.46%-0.41%-24.43%-13.49%6.72%
Upgrade
Enterprise Value
8,2587,2746,4275,2925,0125,627
Upgrade
Last Close Price
48.1038.1235.4834.7444.2649.37
Upgrade
PE Ratio
21.8823.44-26.2420.9419.47
Upgrade
PS Ratio
0.930.730.660.660.780.79
Upgrade
PB Ratio
0.800.810.910.911.071.27
Upgrade
P/TBV Ratio
0.850.971.091.101.341.57
Upgrade
P/FCF Ratio
-156.37--11.1047.11
Upgrade
P/OCF Ratio
254.4927.89-40.616.8621.21
Upgrade
EV/Sales Ratio
1.851.581.361.110.930.92
Upgrade
EV/EBITDA Ratio
27.1430.85913.2387.7218.0111.62
Upgrade
EV/EBIT Ratio
88.51103.01--42.7116.73
Upgrade
EV/FCF Ratio
-162.90337.06--13.3454.96
Upgrade
Debt / Equity Ratio
0.851.161.461.220.620.57
Upgrade
Debt / EBITDA Ratio
15.0916.88112.2144.257.654.18
Upgrade
Debt / FCF Ratio
-224.34--6.4021.18
Upgrade
Asset Turnover
0.380.430.480.540.670.81
Upgrade
Inventory Turnover
1.971.992.262.152.092.54
Upgrade
Quick Ratio
0.600.780.690.821.181.06
Upgrade
Current Ratio
0.981.141.101.211.781.73
Upgrade
Return on Equity (ROE)
5.07%4.45%-8.57%2.02%2.77%3.44%
Upgrade
Return on Assets (ROA)
0.63%0.42%-0.94%-0.68%0.91%2.78%
Upgrade
Return on Capital (ROIC)
0.73%0.51%-1.16%-0.86%1.19%3.64%
Upgrade
Earnings Yield
4.57%4.27%-9.90%3.81%4.78%5.13%
Upgrade
FCF Yield
-1.21%0.64%-27.32%-47.10%9.01%2.12%
Upgrade
Dividend Yield
2.08%2.62%-2.45%3.39%3.65%
Upgrade
Payout Ratio
45.44%--108.28%78.35%63.05%
Upgrade
Buyback Yield / Dilution
-0.23%-0.23%0.24%0.21%-0.07%0.03%
Upgrade
Total Shareholder Return
1.85%2.39%0.24%2.66%3.32%3.67%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.